Lexaria Bioscience Corp. (LEXX) Fundamentals

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
SHARE INFORMATION
Market Cap$ 17,198,384
Shares Outstanding5,950,998
Float4,044,528
Percent Float67.96%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 722,738
Latest Fiscal EPS$ -0.89
Latest Fiscal Date2021-08-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions16
Institutional Holdings Date2021-06-30
Institutional Bought Previous 3 Months40,472
Institutional Holdings Percent8.2%
Institutional Sold Previous 3 Months-
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months10,000
Insider Holdings Percent70.3
Insider Sold Previous 3 Months-
Insider Shares Owned4,184,136
TRADING INFO
52 Week High$ 7.20
52 Week Low$ 1.85
52 Week High Change$ -46.38
21 Day Moving Average$ 2.8646
21 Day Extended Moving Average$ 2.9182
50 Day Moving Average$ 2.7975
50 Day Extended Moving Average$ 2.8301
200 Day Moving Average$ 3.5863
200 Day Extended Moving Average$ 3.5288
10 Day Average Volume89,329
20 Day Average Volume64,841
30 Day Average Volume58,170
50 Day Average Volume65,600
Alpha-0.008514
Beta-0.8786
Standard Deviation0.183833
R20.058202
7 Day Price Change$ -0.3466
7 Day Percent Change-10.71%
21 Day Price Change$ 0.1439
21 Day Percent Change5.24%
30 Day Price Change$ 0.11
30 Day Percent Change3.96%
Month to Date Price Change$ 0.19
Month to Date Percent Change7.04%
Quarter to Date Price Change$ -0.09
Quarter to Date Percent Change-3.02%
180 Day Price Change$ -0.97
180 Day Percent Change-25.13%
200 Day Price Change$ -1.19
200 Day Percent Change-29.17%
Year to Date Price Change$ -1.14
Year to Date Percent Change-28.29%

Lexaria Bioscience Corp. (LEXX) Key Ratios

PROFITABILITY
EBIT Margin-4,092.7%
EBITDA Margin-4,011.8%
Pre-Tax Profit Margin-2,253.9%
Profit Margin Count0.0%
Gross Margin68.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 175,268
Revenue Per Share$ 0.0295
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio40.10
Leverage Ratio1.00
Quick Ratio36.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.40
Enterprise Value$ 10,284,399
Price to Sales98.1262
Price to Free Cash-3.60
PE High Last 5 Years-8.60
Price To Book1.90
Price To Cash Flow29.80
PE Low Last 5 Years-8.00
Price to Tangible Book2.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.90
Invoice Turnover1.10
Assets Turnover0.00
Return Assets-72.70
Return on Equity-73.27
Return on Capital-70.86

Lexaria Bioscience Corp. (LEXX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDavidson & Company LLP
CEOChristopher Bunka
Emplyoees6
Last AuditUQ
CIK0001348362
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address740 McCurdy Road
Suite 100
Kelowna, BC V1X 2P7
Websitehttps://www.lexariabioscience.com
Facsimile-
Telephone+1 250 765-6424
Emailir@lexariabioscience.com


Your Recent History
NASDAQ
LEXX
Lexaria Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.